Literature DB >> 8455148

Blood transfusion as a major risk factor for HTLV-I infection among hospitalized children in Gabon (Equatorial Africa).

E Delaporte1, M Peeters, J L Bardy, Y Ville, L Placca, I Bedjabaga, B Larouzé, P Piot.   

Abstract

To study the risk factors for HTLV-I infection of African infants living in a high seroprevalence area, a survey was conducted among hospitalized children and their mothers in Franceville, southern Gabon. A total of 610 children (6 months to 14 years old) from 555 families and 434 mothers participated in the study. HTLV-I seroprevalence was 7.1% in the mothers and 2.8% in the children. No increase by age was observed in the children. Significantly more children with sickle cell anemia (11 of 57, or 19.2%) were infected than others (1%) (Fisher's exact test p < 0.001). Of the 13 seropositive infants (C+) whose mothers were tested, six (43%) had a seropositive mother (M+) [p < 0.001, prevalence ratio (PR) 10.12, 95% CI 3.40-30.35, attributable risk (AR) 0.55]. Risk factors for nonmaternally acquired HTLV-I infection were previous blood transfusion (Fisher's exact test p < 0.001, PR 15.74, CI 5.20-47.60, AR 0.71) and hospital admission. In a hospitalized pediatric population in Gabon mother-to-child transmission and blood transfusion (because of sickle cell disease) were equally implicated in HTLV-I infection. Control of HTLV-I infection in children in Africa requires prevention of both vertical and transfusion-associated transmission, which may be exceedingly difficult in developing countries.

Entities:  

Mesh:

Year:  1993        PMID: 8455148

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  5 in total

1.  One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, and 3.

Authors:  Guillaume Besson; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

2.  Risk factors for HTLV-1 infection in Central Africa: A rural population-based survey in Gabon.

Authors:  Delia Doreen Djuicy; Augustin Mouinga-Ondémé; Olivier Cassar; Jill-Léa Ramassamy; Antony Idam Mamimandjiami; Rodrigue Bikangui; Arnaud Fontanet; Antoine Gessain
Journal:  PLoS Negl Trop Dis       Date:  2018-10-12

Review 3.  Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in Africa.

Authors:  James M Fox; Nora Mutalima; Elizabeth Molyneux; Lucy M Carpenter; Graham P Taylor; Martin Bland; Robert Newton; Fabiola Martin
Journal:  Trop Med Int Health       Date:  2016-02-03       Impact factor: 2.622

4.  Revisiting human T-cell lymphotropic virus types 1 and 2 infections among rural population in Gabon, central Africa thirty years after the first analysis.

Authors:  Melanie Caron; Guillaume Besson; Cindy Padilla; Maria Makuwa; Dieudonne Nkoghe; Eric Leroy; Mirdad Kazanji
Journal:  PLoS Negl Trop Dis       Date:  2018-10-25

5.  High prevalence of human T-cell leukemia virus type-1b genotype among blood donors in Gabon, Central Africa.

Authors:  Jill-Léa Ramassamy; Olivier Cassar; Manoushka Toumbiri; Abdoulaye Diané; Antony Idam Mamimandjiami; Calixte Bengone; Jophrette Mireille Ntsame-Ndong; Augustin Mouinga-Ondémé; Antoine Gessain
Journal:  Transfusion       Date:  2020-05-15       Impact factor: 3.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.